Kilitch Drugs (India): Rectification of typo error in the outcome of Board meeting dated 22nd October 2026'
Kilitch Drugs (India) (KILITCH) filed a disclosure titled "Rectification of typo error in the outcome of Board meeting dated 22nd October 2026'". The company is valued at about ₹701 crore.
What happened
Kilitch Drugs (India) (KILITCH) filed a disclosure with the exchanges on 12 November 2026 at 06:49 PM titled "Rectification of typo error in the outcome of Board meeting dated 22nd October 2026'".
Company snapshot
Kilitch Drugs (India) is a micro-cap company, with a market value of about ₹701 crore.
The stock last traded at ₹200.5, against a 52-week range of ₹117.3–₹267.9 (25.1% below the high).
Before this filing the shares had moved −17.0% over the month and +4.3% over three months. Average daily turnover over the last 20 sessions was about ₹1.31 crore.
Promoters held 63.77% at the end of Q2 FY27. Foreign institutions owned 0.11% and domestic institutions 0.50%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 49 | 8.2 | 4.97 |
| Q3 FY26 | 54 | 4.4 | 2.5 |
| Q4 FY26 | 90 | 14.5 | 4.24 |
| Q1 FY27 | 45 | 2.9 | 0.83 |
| Q2 FY27 | 50 | 1.4 | 0.64 |
What history shows
BCEIE's records show 4 previous board meeting filings from the company since May 2026.
After those filings, the stock gained 1.4% on average the next trading day and was down 3.3% on average after five days (3 filings with price data).
Market-wide, 3,333 board meeting filings with an impact score of 50 or more saw an average next-day move of +0.0%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 2 Nov 2026 | Kilitch Drugs India Ltdhas informed BSE that the meeting of the… | +1.6% | — |
| 10 Aug 2026 | Board Meeting Intimation for Considering And Approval Of Unaudited… | −1.1% | −10.8% |
| 28 Jul 2026 | Board Meeting Outcome for Outcome Of Board Meeting | +3.8% | +4.2% |
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.